Healthcare - Biotechnology - NASDAQ - IE
$ 28.19
-0.564 %
$ 4.56 B
Market Cap
12.7
P/E
Price Target
Average
26.37%
Revenue Forecast
Estimate
--2.84%
EBIT
Estimate
--51.34%
Net Income
Estimate
--2.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alkermes plc
Wall Street analysts predict an average 1-year price target for ALKS of $35.6 , with forecasts ranging from a low of $25 to a high of $50 .
ALKS Lowest Price Target
Wall Street Target
25 USD
-11.32%
ALKS Average Price Target
Wall Street Target
35.6 USD
26.37%
ALKS Highest Price Target
Wall Street Target
50 USD
77.37%
REVENUE FORECAST
Revenue Forecast Chart ALKS
EBIT FORECAST
EBIT Forecast Chart ALKS
NET INCOME FORECAST
Net Income Chart ALKS